Medicare Enrolled
Dr. Michelle Tarbox, MD
Dermatopathology Physician · Lubbock, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tarbox from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tarbox?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tarbox
Dr. Michelle Tarbox is a dermatopathology physician in Lubbock, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Tarbox performed 3,777 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Tarbox received a total of $59,639 from 39 pharmaceutical and/or device companies across 356 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tarbox is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 39% volume in TX
$59,639 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,777
Medicare services
Top 39% in TX for dermatopathology physician
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,591 | $5 | $18 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
509 | $48 | $193 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
441 | $60 | $155 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
400 | $34 | $136 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
269 | $75 | $230 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $79 | $220 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
74 | $63 | $208 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
55 | $75 | $190 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $34 | $95 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
39 | $112 | $342 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
28 | $448 | $1,363 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
23 | $39 | $105 |
| Surgical pathology consultation on referred slides A pathologist reviews and reports on tissue slides that were prepared at another facility. This service provides a second opinion or expert analysis of the existing samples. |
23 | $67 | $203 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
22 | $96 | $299 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
22 | $26 | $107 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 18 | $321 | $829 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
15 | $190 | $619 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
14 | $84 | $259 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
14 | $48 | $209 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
14 | $73 | $250 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
14 | $130 | $361 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $113 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$59,639
Total received (2018-2024)
Avg $8,520/year across 7 years
Top 4% in TX for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
356
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$46,685
2023
$8,369
2022
$1,338
2021
$1,272
2020
$562
2019
$949
2018
$464
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$19,955
UCB, Inc.
$10,789
GENZYME CORPORATION
$7,471
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,298
Galderma Laboratories, L.P.
$498
Regeneron Healthcare Solutions, Inc.
$447
E.R. Squibb & Sons, L.L.C.
$258
GlaxoSmithKline, LLC.
$218
SUN PHARMACEUTICAL INDUSTRIES INC.
$206
Amgen Inc.
$198
Incyte Corporation
$189
PFIZER INC.
$183
Ortho Dermatologics, a division of Bausch Health US, LLC
$143
Genentech USA, Inc.
$137
Lilly USA, LLC
$120
Arcutis Biotherapeutics, Inc.
$120
LEO Pharma Inc.
$111
ABBVIE INC.
$104
Krystal Biotech Inc
$72
Janssen Biotech, Inc.
$53
Dermavant Sciences, Inc.
$49
Kyowa Kirin, Inc.
$47
Journey Medical Corporation
$19
Top 3 companies account for 81.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$20,232
UCB, Inc.
$10,960
GENZYME CORPORATION
$10,741
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,560
NOVARTIS PHARMACEUTICALS CORPORATION
$2,800
Lilly USA, LLC
$958
Amgen Inc.
$883
Regeneron Healthcare Solutions, Inc.
$872
Galderma Laboratories, L.P.
$650
AbbVie Inc.
$638
Sun Pharmaceutical Industries Inc.
$488
PFIZER INC.
$479
AbbVie, Inc.
$462
Arcutis Biotherapeutics, Inc.
$386
ABBVIE INC.
$384
Genentech USA, Inc.
$342
E.R. Squibb & Sons, L.L.C.
$315
Janssen Scientific Affairs, LLC
$243
GlaxoSmithKline, LLC.
$218
SUN PHARMACEUTICAL INDUSTRIES INC.
$217
Incyte Corporation
$211
LEO Pharma Inc.
$200
Journey Medical Corporation
$178
Ortho Dermatologics, a division of Bausch Health US, LLC
$143
Kyowa Kirin, Inc.
$129
Acerta Pharma LLC
$107
AstraZeneca Pharmaceuticals LP
$100
Biofrontera Inc.
$98
Kerecis Limited
$96
Celgene Corporation
$91
Dermavant Sciences, Inc.
$90
Eli Lilly and Company
$80
Krystal Biotech Inc
$72
Janssen Biotech, Inc.
$53
Tactile Systems Technology Inc
$46
Regeneron Pharmaceuticals, Inc.
$45
Foundation Medicine, Inc.
$33
Stemline Therapeutics Inc.
$24
Medline Industries, Inc.
$13
Top 3 companies account for 70.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · AREXVY · Absorica LD · Ameluz · BLU-U · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · DUPIXENT · ELZONRIS · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · FASENRA · FLEXITOUCH · FOUNDATIONONE · Flexitouch Plus · HUMIRA · Humira · Hyalomatrix Wound Device · ILUMYA · Ilumya · Kerecis Omega3 SurgiClose · LIBTAYO · LITFULO · NUCALA · OLUMIANT · OPZELURA · Otezla · POTELIGEO · Poteligeo · QBREXZA · RINVOQ · Rituxan · SKYRIZI · SPEVIGO · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · VYJUVEK · Winlevi · Xolair · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tarbox is a clinical cardiology specialist, with moderate Medicare volume, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tarbox experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Tarbox performed 1,591 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Tarbox receive payments from pharmaceutical companies?
Yes. Dr. Tarbox received a total of $59,639 from 39 companies across 356 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tarbox's costs compare to other dermatopathology physicians in Lubbock?
Dr. Tarbox's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tarbox) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Lubbock
Browse dermatopathology physicians in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in TX
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in TX
Which TX dermatopathology physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology